Dec 20 (Reuters) - Proteomics International Laboratories Ltd (PIQ) :
- SIGNED A LICENCE AGREEMENT FOR SALE OF PROMARKERD PREDICTIVE TEST FOR DIABETIC KIDNEY DISEASE IN CHILE
- DEAL EXPANDS LONG-STANDING PARTNERSHIP WITH BIOTECHNOLOGY COMPANY OMICS GLOBAL SOLUTIONS
News: PIQ Proteomics International Laboratories Says Signed A Licence Agreement
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
0.005(1.67%) |
Mkt cap ! $49.92M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 31.0¢ | 30.0¢ | $55.40K | 183.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 55452 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 12318 | 4 |
View Market Depth
| Last trade - 12.28pm 04/09/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |